The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 575,912 | 37,300 | SH | Call | SOLE | 37,300 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,781,000 | 260,000 | SH | Put | SOLE | 260,000 | 0 | 0 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | 986,700 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | |||
AEGLEA BIOTHERAPEUTICS INC | COM NEW | 00773J202 | 2,968,138 | 242,297 | SH | SOLE | 242,297 | 0 | 0 | |||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 296,245 | 44,348 | SH | SOLE | 44,348 | 0 | 0 | |||
ALKERMES PLC | SHS | G01767105 | 5,602,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 2,801,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,945,200 | 130,000 | SH | Put | SOLE | 130,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,521,600 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 22,260,843 | 1,045,110 | SH | SOLE | 1,045,110 | 0 | 0 | |||
ARAVIVE INC | COM | 03890D108 | 45,739 | 346,511 | SH | SOLE | 346,511 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 14,352,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 6,965,000 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 4,344,896 | 46,400 | SH | SOLE | 46,400 | 0 | 0 | |||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,063,200 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 7,462,238 | 1,000,300 | SH | SOLE | 1,000,300 | 0 | 0 | |||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 4,642,446 | 1,992,466 | SH | SOLE | 1,992,466 | 0 | 0 | |||
AVROBIO INC | COM | 05455M100 | 770,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
BIOATLA INC | COM | 09077B104 | 306,000 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 784,358 | 30,156 | SH | SOLE | 30,156 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 16,407,550 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 791,100 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 4,128,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 6,587,049 | 1,018,091 | SH | SOLE | 1,018,091 | 0 | 0 | |||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 14,954,882 | 685,061 | SH | SOLE | 685,061 | 0 | 0 | |||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 496,514 | 328,817 | SH | SOLE | 328,817 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 13,383,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 16,838,996 | 1,129,376 | SH | SOLE | 1,129,376 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 6,786,582 | 230,366 | SH | SOLE | 230,366 | 0 | 0 | |||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 2,954,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 11,733,030 | 239,108 | SH | SOLE | 239,108 | 0 | 0 | |||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 6,869,800 | 140,000 | SH | Call | SOLE | 140,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,238,450 | 155,000 | SH | Put | SOLE | 155,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 2,316,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 662,702 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 11,517,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 4,917,759 | 128,100 | SH | Put | SOLE | 128,100 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 968,789 | 325,097 | SH | SOLE | 325,097 | 0 | 0 | |||
INOZYME PHARMA INC | COM | 45790W108 | 5,795,378 | 1,379,852 | SH | SOLE | 1,379,852 | 0 | 0 | |||
INSPIRE MED SYS INC | COM | 457730109 | 1,248,783 | 6,293 | SH | SOLE | 6,293 | 0 | 0 | |||
INSULET CORP | COM | 45784P101 | 797,450 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,679,952 | 278,292 | SH | SOLE | 278,292 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 6,670,000 | 57,500 | SH | SOLE | 57,500 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 7,811,599 | 856,535 | SH | SOLE | 856,535 | 0 | 0 | |||
LANTHEUS HLDGS INC | COM | 516544103 | 2,084,400 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
LIANBIO | SPONSORED ADS | 53000N108 | 1,001,812 | 672,357 | SH | SOLE | 672,357 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 12,413,400 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 3,619,500 | 2,850,000 | SH | SOLE | 2,850,000 | 0 | 0 | |||
MESOBLAST LTD | SPONS ADR | 590717104 | 492,000 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,038,711 | 335,068 | SH | SOLE | 335,068 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 2,632,157 | 60,426 | SH | SOLE | 60,426 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 948,000 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 2,850,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 6,185,700 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 1,145,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 1,156,250 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 260,300 | 137,000 | SH | SOLE | 137,000 | 0 | 0 | |||
NLS PHARMACEUTICS LTD | SHS | H57830103 | 140,319 | 200,455 | SH | SOLE | 200,455 | 0 | 0 | |||
NURIX THERAPEUTICS INC | COM | 67080M103 | 1,965,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 2,298,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
NUVATION BIO INC | COM CL A | 67080N101 | 335,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 526,677 | 265,958 | SH | SOLE | 265,958 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 3,822,076 | 79,214 | SH | SOLE | 79,214 | 0 | 0 | |||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 532,178 | 202,349 | SH | SOLE | 202,349 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 7,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 1,752,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 4,347,000 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 2,121,500 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 961,353 | 41,581 | SH | SOLE | 41,581 | 0 | 0 | |||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 1,124,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,941,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 1,634,750 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 20,400,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 11,220,000 | 1,100,000 | SH | Call | SOLE | 1,100,000 | 0 | 0 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 1,077,953 | 400,726 | SH | SOLE | 400,726 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 894,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 1,274,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 6,003,763 | 368,329 | SH | SOLE | 368,329 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,681,882 | 332,600 | SH | Put | SOLE | 332,600 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,321,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 10,262,962 | 300,438 | SH | SOLE | 300,438 | 0 | 0 |